-
Lilly Licensing Autoimmune Therapy in $400M Deal
Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system.
-
Clinical Trial Begins for Liver Dialysis Device
A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option.
-
S&P 500 Tech Stocks Surpass Dot-Com Peak
On Wednesday, Standard & Poor’s index of 500 stocks in the information technology industry closed at 992.29, its highest point since March 2000, at the height of the dot-com boom, when the index reached 988.49.
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Robot Designed to Grow into Shapes, Spaces
Engineering researchers created a new type of robot that grows to extend its form into spaces like a vine, rather than move to different locations.
-
Start-Up Building Mobile Apps Combining DNA, Lifestyle
A new enterprise in California is creating smartphone apps that provide lifestyle advice based on DNA analysis and activity tracking.
-
Stem Cell Clinics Found Marketing in ClinicalTrials.gov
A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services.
-
Patent Awarded for Exosome Capture Process
A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses.
-
Start-Up Offering Precise Heart Rhythm Diagnostic
A one year-old company in New York City is developing a device that assesses the severity of heart rhythm problems to prescribe a more precise course of treatment.
-
Biotech Licensing Viral T-Cell Immunotherapies
A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine.